PYRUVATEKINASE MODULATORS AND THEIR USE Russian patent published in 2023 - IPC A61K31/5025 C07D513/14 A61P7/08 A61P7/06 A61P35/00 A61P3/10 

Abstract RU 2797518 C2

FIELD: pharmacology.

SUBSTANCE: document describes methods of using compounds of formula (I) to modulate PKM2 activity in a subject. The invention relates to the field of pharmacology and medicine and is aimed at modulating the activity of M2-pyruvate kinase (PKM2). The use of a compound selected from the group or a pharmaceutically acceptable salt of any of the above compounds for the treatment of diseases associated with abnormal PKM2 activity is disclosed, the disease being selected from the group consisting of cancer, obesity, diabetes-related disease, atherosclerosis, coronary artery disease (CAD), Bloom's syndrome (BS), or an autoimmune disease.

EFFECT: invention provides effective treatment of diseases associated with PKM2 activity.

20 cl, 14 dwg, 29 tbl, 11 ex

Similar patents RU2797518C2

Title Year Author Number
MEDICINAL COMPOUNDS 2014
  • Kharrison Timoti
  • Trevitt Grekhem
  • Khyuitt Piter Robin
  • O'Doud Kolin Roderik
  • Burkamp Frank
  • Uilkinson Endryu Dzhon
  • Sheferd Stiven D.
  • Miel Yug
RU2691105C1
NITROIMIDAZOLE DERIVATIVE AGAINST PULMONARY TUBERCULOSIS 2016
  • Luo, Wei
  • Ding, Charles Z.
  • Huang, Zhigang
  • Chen, Shuhui
RU2675622C1
AZALACTAM COMPOUNDS AS HPK1 INHIBITORS 2019
  • Gallego, Rebekka Enn
  • Nair, Sadzhiv Krishnan
  • Kania, Robert Stiven
  • Akhmad, Omar Kkhaled
  • Dzhonson, Ted Uillyam
  • Tattl, Dzhejmison Brajs
  • Dzhalej, Mekhran
  • Maktig, Mishel Enn
  • Chzhou, Dakhuej
  • Del Bel, Mettyu L.
  • Chzhou, Ru
  • Khe, Mining
  • Shmitt, Anne-Mari Dechert
RU2801140C2
INHIBITORS OF CDK 2011
  • Tavares Fransis Kh.
  • Strum Dzhej S.
RU2621674C2
HETEROCYCLIC COMPOUNDS AND METHODS OF APPLICATION 2009
  • Baehll Dzhonatan Bajldon
  • Buj Chinkh Tkhien
  • Kolmen Piter
  • Chabotar Piter
  • Dadli Danett A.
  • Fehjrbrazer Uehjn Dzh.
  • Flajgehr Dzhon A.
  • Lessin Gijom Loran
  • Ndubaku Chudi
  • Nikolakopulos Dzhordzh
  • Slibs Brehd Ehdmund
  • Smit Brajan Dzhon
  • Uotson Kejt Dzheffri
  • Ehlmor Stiven V.
  • Khasvol'D Liza A.
  • Petros Ehndrju M.
  • Sauehrs Ehndrju Dzh.
  • Tao Chzhi-Fu
  • Van Leh
  • Van Silu
  • Dezej Kurt
RU2525116C2
PROTEIN KINASE INHIBITORS FOR ENHANCING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH 2019
  • Albrecht, Wolfgang
  • Laufer, Stefan
  • Selig, Roland
  • Kloevekorn, Phillip
  • Praefke, Bent
RU2822216C2
MACROCYCLIC COMPOUNDS AS STING AGONISTS AND METHODS USING THEM AND WAYS OF USE THEREOF 2020
  • Karche, Navnath Popat
  • Banerjee, Moloy
  • Gupta, Nishant Ramnivasji
  • Jadhav, Ganesh Rajaram
  • Vyavahare, Vinod Popatrao
  • Das, Amit Kumar
  • Walke, Deepak Sahebrao
  • Kalhapure, Vaibhav Madhukar
  • Bhoskar, Smita Aditya
  • Ramdas, Vidya
  • Palle, Venkata P.
  • Kamboj, Rajender Kumar
RU2825271C2
BICYCLIC DIHYDROPYRIMIDINECARBOXAMIDE DERIVATIVES AS RHO-KINASE INHIBITORS 2017
  • Accetta, Alessandro
  • Rancati, Fabio
  • Capelli, Anna Maria
  • Clark, David Edward
  • Tisselli, Patrizia
  • Edwards, Christine
  • Bhalay, Gurdip
RU2778478C2
PYRAZOLO[1,5-A]PYRIMIDINYLCARBOXAMIDES AND THEIR USE FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS 2017
  • Skerlj, Renato, T.
  • Bourque, Elyse Marie Josee
  • Lansbury, Peter, T.
  • Good, Andrew, C.
RU2799332C2
BROMDOMAIN INHIBITORS 2012
  • Wang, Le
  • Pratt, John K.
  • Mcdaniel, Keith F.
  • Dai, Yujia
  • Fidanze, Steven D.
  • Hasvold, Lisa
  • Holms, James H.
  • Kati, Warren M.
  • Liu, Dachun
  • Mantei, Robert A.
  • Mcclellan, William J.
  • Sheppard, George S.
  • Wada, Carol K.
RU2671571C1

RU 2 797 518 C2

Authors

Chianketta, Dzhovanni

Kung, Charlz

Lyu, Tao

Padyana, Anil, Kumar

Suj, Chzhikhua

Tsaj, Chzhenvej

Tsuj, Davej

Tszi, Tszintszin

Dates

2023-06-06Published

2018-08-15Filed